SURGSurgePays, Inc.
The schedule
- Thu1Oct
With SurgePays’ share price hovering below $1.00 and recent weakness to $0.72, an extended period under the minimum bid could trigger Nasdaq compliance actions; from a base price of $0.55, the company may be forced to pursue a reverse split or secure a sustainable recovery, with material sentiment implications.
- Thu15Oct
SurgePays’ strategy around underbanked consumers and prepaid wireless creates ongoing optionality for a material distribution partnership with a larger carrier, retailer, or payments platform; from a base price of $0.55, a credible partnership announcement could re-rate the equity sharply toward $1.10, while failure to secure such deals would likely leave the stock drifting near $0.45.
- Wed11Nov
- Wed11Aug
Q3 2026 results will provide a fuller picture of whether SurgePays has structurally improved margins and funding visibility; from a base price of $0.55, the market will use this print and early 2027 commentary to decide whether the company is transitioning out of distress or remains a highly speculative turnaround.
Past
- Wed12Aug
Q2 2026 results will update the market on whether SurgePays can sustain high revenue growth while narrowing losses; from a base price of $0.55, investors will key in on EBITDA trajectory, operating cash flow, and any signs that the business model is scaling toward profitability.
- Sat1Aug
Given negative shareholders' equity and shrinking cash, SurgePays may pursue an equity or convertible financing around mid-2026; from a base price of $0.55 this balance sheet event could either de-risk the story if structured well or drive the stock toward $0.70 if it is highly dilutive.
- Thu16Apr
First look at Q1 2026 results and updated 2026 guidance from SurgePays at a time when the stock is trading at $0.72 near 52-week lows, with strong top-line growth but deepening losses and negative free cash flow; the market will focus on whether management can show a credible path to profitability and stabilize cash burn.
Scouting Reports
Sticky Inflation and Rising Yields Test Warsh’s New Fed
May 19, 2026
The U.S.-Iran ceasefire initially uncorked a wave of relief across global capital markets, sending broad proxies like SPY into a multi-week risk-on sprint. But beneath the surface, the foundation of t
Read more →
De-escalation, Hyperscaler Capex, and the Physical Realities of the AI Arms Race
Apr 18, 2026
The unofficial de-escalation of the Iran conflict has removed a significant macro overhang, clearing the path for the Information Technology sector to resume its structural breakout. With the geopolit
Read more →
Defense Stocks Surge as Dow Tumbles 785 Points on Iran Conflict Escalation
Mar 6, 2026
Wall Street is currently repricing risk in real-time. Following reported strikes involving U.S. and Israeli forces and the escalation of the conflict in Iran, the broad market has stumbled, but a clea
Read more →